| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.086 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |